Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: The Pre-POINT randomized clinical trial

Pre-POINT Study Group

doi:10.1089/dia.2016.2509

Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: The Pre-POINT randomized clinical trial

Pre-POINT Study Group

Department of Pediatric Medicine

Center for Regenerative Therapies Dresden
Technischen Universität Dresden
Forschergruppe Diabetes e. V.
Technical University of Munich
University of Colorado Denver School of Medicine
Medical University of Vienna
University of Bristol
Ludwig-Maximilians-Universität München
Helmholtz Zentrum München German Research Center for Environmental Health
Medizinische Hochschule Hannover

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	S97-S98
Journal	Diabetes Technology and Therapeutics
Volume	18
DOIs	https://doi.org/10.1089/dia.2016.2509
State	Published - Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1089/dia.2016.2509

Cite this

@article{b70a7af47ceb462d8c351c6661143196,

title = "Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: The Pre-POINT randomized clinical trial",

author = "\{Pre-POINT Study Group\} and E. Bonifacio and Ziegler, \{A. G.\} and G. Klingensmith and E. Schober and Bingley, \{P. J.\} and M. Rottenkolber and A. Theil and A. Eugster and R. Puff and C. Peplow and F. Buettner and K. Lange and J. Hasford and P. Achenbach",

year = "2016",

month = feb,

doi = "10.1089/dia.2016.2509",

language = "English",

volume = "18",

pages = "S97--S98",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes

T2 - The Pre-POINT randomized clinical trial

AU - Pre-POINT Study Group

AU - Bonifacio, E.

AU - Ziegler, A. G.

AU - Klingensmith, G.

AU - Schober, E.

AU - Bingley, P. J.

AU - Rottenkolber, M.

AU - Theil, A.

AU - Eugster, A.

AU - Puff, R.

AU - Peplow, C.

AU - Buettner, F.

AU - Lange, K.

AU - Hasford, J.

AU - Achenbach, P.

PY - 2016/2

Y1 - 2016/2

UR - https://www.scopus.com/pages/publications/84957627609

U2 - 10.1089/dia.2016.2509

DO - 10.1089/dia.2016.2509

M3 - Comment/debate

AN - SCOPUS:84957627609

SN - 1520-9156

VL - 18

SP - S97-S98

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -

Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: The Pre-POINT randomized clinical trial

UN SDGs

Access to Document

Other files and links

Cite this